+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bifidobacterium Infantis Market - Global Forecast 2026-2032- Product Image
Bifidobacterium Infantis Market - Global Forecast 2026-2032- Product Image
Sale

Bifidobacterium Infantis Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125672
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bifidobacterium Infantis Market is projected to reach USD 1.08 Billion in 2026. It is expected to continue growing at a CAGR of 8.81%, reaching USD 1.81 Billion by 2032.

Bifidobacterium infantis: Executive Overview

Bifidobacterium infantis is an infant-associated probiotic bacterium studied for its role in early-life gut ecology, especially its ability to utilize human milk oligosaccharides. Research commonly examines its relationships with intestinal barrier function, immune development, microbial balance, and inflammatory processes. Clinical interpretation remains strain-specific, and evidence varies by formulation, population, endpoint, and study design.

Early-Life Microbiome Research Is Reshaping the Landscape

The field is moving from generic probiotic positioning toward more precise characterization of strains, genomic traits, manufacturing quality, and host context. Greater attention is being given to breastfed versus formula-fed infants, antibiotic exposure, prematurity, gastrointestinal symptoms, and the interaction between microbial supplementation and human milk components. Regulatory expectations, clinical-trial quality, and substantiation of health claims are also becoming more important as products move closer to specialized nutrition and therapeutic applications.

Artificial Intelligence Accelerates Strain and Evidence Analysis

Artificial intelligence can support this field by analyzing microbial genomes, predicting carbohydrate-utilization pathways, identifying strain-level differences, and integrating longitudinal microbiome, clinical, and metabolomic datasets. It can also improve literature screening, trial recruitment, quality monitoring, and formulation optimization. However, AI-generated associations do not establish clinical benefit; findings still require controlled studies, transparent validation, reproducible bioinformatics, and careful assessment of safety in vulnerable infants.

Regional Insights Across Six Geographies

North America emphasizes clinical validation, regulatory documentation, neonatal research, and specialized nutrition pathways. Europe places strong weight on precautionary assessment, strain characterization, and harmonized food and health-claim standards. Asia-Pacific combines substantial infant-nutrition research with diverse feeding practices and regulatory systems, creating opportunities for locally relevant evidence. Latin America is shaped by unequal access to advanced diagnostics, varied regulatory capacity, and interest in affordable maternal and infant health interventions. The Middle East is developing nutrition and healthcare capabilities while facing differences in import dependence and clinical infrastructure. Africa presents important research needs linked to nutrition, infectious disease, microbiome diversity, and access, with study designs requiring strong local partnerships and context-sensitive endpoints.

Group-Level Priorities in ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries may benefit from coordinated approaches to quality standards, infant-nutrition research, and evidence generation across diverse populations. BRICS members span major research, manufacturing, and public-health systems, but require attention to regulatory divergence and equitable access. The European Union is particularly relevant for harmonized safety, novel-food, and health-claim considerations. G7 members contribute advanced clinical, genomic, and regulatory capabilities, while NATO countries may share research infrastructure and preparedness capabilities without making defense relevance central to this health topic. GCC states are positioned to strengthen specialized healthcare, import-quality oversight, and regional clinical collaboration.

Country Insights: Diverse Evidence and Regulatory Contexts

Australia combines strong food-science and clinical research capabilities with high expectations for product quality. Brazil and Mexico have large, diverse populations and important needs for locally generated infant-health evidence. Canada and the United States emphasize clinical substantiation, specialized nutrition, and regulatory compliance. China, India, Japan, and South Korea offer substantial research and manufacturing capabilities, while their regulatory pathways and consumer practices differ. France, Germany, Italy, and Spain operate within the European framework and contribute expertise in neonatology, nutrition, microbiology, and clinical research. The United Kingdom maintains strong academic and healthcare research capacity under its distinct post-EU regulatory setting. Russia presents a separate regulatory and research environment requiring careful assessment of data access, standards, and collaboration conditions.

Actions for Leaders: Build Strain-Specific, Clinically Credible Programs

Industry leaders should prioritize strain-level identity, genomic stability, contamination controls, and transparent documentation from culture collection through finished product. Clinical programs should define relevant infant populations, account for feeding and antibiotic exposures, use prespecified endpoints, and monitor adverse events over appropriate time horizons. Partnerships with hospitals, pediatric researchers, milk-banking or lactation specialists, and public-health institutions can improve study relevance. Leaders should also establish region-specific regulatory plans, avoid broad claims unsupported by evidence, and use AI as a decision-support tool rather than a substitute for clinical validation.

Methodology: Evidence Triangulation and Contextual Assessment

This executive summary uses a structured review approach centered on the biological characteristics and research applications of Bifidobacterium infantis. Interpretation should triangulate peer-reviewed mechanistic studies, strain-level genomic evidence, randomized or controlled clinical research, safety reporting, regulatory materials, and relevant guidance on infant nutrition and probiotics. Findings should be separated by strain, formulation, population, comparator, and outcome, with particular attention to study quality, reproducibility, confounding factors, and applicability across regions. No market estimates, forecasts, company comparisons, or market-share assessments are included.

Conclusion: Precision and Evidence Will Define Progress

Bifidobacterium infantis remains a scientifically important component of early-life microbiome research, but its potential should be evaluated through strain-specific biology and appropriately designed clinical studies rather than broad category assumptions. Progress will depend on reliable manufacturing, clear regulatory positioning, representative research populations, and transparent reporting of benefits and limitations. Organizations that combine rigorous evidence generation with responsible claims and regional sensitivity will be best positioned to translate microbiome science into credible infant-health applications.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bifidobacterium Infantis Market, by Application
7.1. Introduction
7.2. Animal Feed
7.2.1. Poultry
7.2.2. Swine
7.3. Clinical Therapeutics
7.3.1. Allergies
7.3.2. Gastrointestinal Disorders
7.3.3. Immune Disorders
7.4. Dietary Supplements
7.4.1. Capsules
7.4.2. Sachets
7.5. Infant Nutrition
7.5.1. Liquid
7.5.2. Powder
7.5.3. Ready To Use
8. Bifidobacterium Infantis Market, by Product Form
8.1. Introduction
8.2. Capsule
8.2.1. Hard Gelatin
8.2.2. Veg Capsules
8.3. Liquid
8.3.1. Suspension
8.3.2. Syrup
8.4. Powder
8.4.1. Bulk
8.4.2. Premix
8.5. Sachet
8.5.1. Multipack
8.5.2. Single Dose
9. Bifidobacterium Infantis Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Homecare
9.4. Hospitals
10. Bifidobacterium Infantis Market, by Distribution Channel
10.1. Introduction
10.2. Online
10.2.1. Company Websites
10.2.2. E-Commerce Platforms
10.3. Offline
11. Bifidobacterium Infantis Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Bifidobacterium Infantis Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Bifidobacterium Infantis Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Alimentary Health Limited
15.2. Alpspure Lifesciences Private Limited
15.3. Archer Daniels Midland Company
15.4. Bifido Co., Ltd.
15.5. Bio Fermen Private Limited
15.6. Biocodex, Inc.
15.7. BioGaia AB
15.8. Brukem Life Care Pvt. Ltd.
15.9. Chr. Hansen Holding A/S
15.10. Culture Systems Inc
15.11. Danone S.A.
15.12. DuPont de Nemours, Inc.
15.13. Evolve Biosystems
15.14. Fengchen Group Co., Ltd.
15.15. GLAC Biotech
15.16. Kerry Group PLC
15.17. Lallemand Inc.
15.18. Morinaga Milk Industry Co., Ltd.
15.19. Nestlé S.A.
15.20. Ninsar Nutrascience Private Limited
15.21. Probi AB
15.22. Probiotical SpA
15.23. Sabinsa Corporation
15.24. Sacco System
15.25. Sapra Healthcare
15.26. SK BIOBIZ AGRO PRIVATE LIMITED
15.27. Synbio Tech Inc.
15.28. Unique Biotech Limited
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Bifidobacterium Infantis Market, Years Considered for the Study
FIGURE 2. Global Bifidobacterium Infantis Market, Research Design
FIGURE 3. Global Bifidobacterium Infantis Market, Research Framework
FIGURE 4. Global Bifidobacterium Infantis Market, Data Triangulation
FIGURE 5. Global Bifidobacterium Infantis Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Bifidobacterium Infantis Market Size, by Application, 2025 vs 2032 (%)
FIGURE 7. Global Bifidobacterium Infantis Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Bifidobacterium Infantis Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 9. Global Bifidobacterium Infantis Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Bifidobacterium Infantis Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Bifidobacterium Infantis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Bifidobacterium Infantis Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Bifidobacterium Infantis Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Bifidobacterium Infantis Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Bifidobacterium Infantis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Bifidobacterium Infantis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Bifidobacterium Infantis Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Bifidobacterium Infantis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Bifidobacterium Infantis Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Bifidobacterium Infantis Market Segmentation & Coverage
TABLE 2. Global Bifidobacterium Infantis Market Size, 2017-2032 (USD Million)
TABLE 3. Global Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 4. Global Animal Feed Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Animal Feed Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Animal Feed Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Swine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Swine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Swine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Clinical Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Clinical Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Clinical Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Allergies Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Allergies Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Allergies Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Gastrointestinal Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Gastrointestinal Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Gastrointestinal Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Immune Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Immune Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Immune Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Dietary Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Dietary Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Dietary Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Sachets Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Sachets Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Sachets Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Infant Nutrition Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Infant Nutrition Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Infant Nutrition Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Ready To Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Ready To Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Ready To Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 47. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Hard Gelatin Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Hard Gelatin Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Hard Gelatin Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Veg Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Veg Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Veg Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Suspension Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Suspension Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Suspension Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Syrup Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Syrup Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Syrup Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Bulk Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Bulk Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Bulk Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Premix Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Premix Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Premix Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Sachet Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Sachet Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Sachet Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Multipack Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Multipack Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Multipack Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Single Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Single Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Single Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Homecare Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Homecare Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Homecare Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 94. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Company Websites Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Company Websites Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Company Websites Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global E-Commerce Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global E-Commerce Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global E-Commerce Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Bifidobacterium Infantis Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Bifidobacterium Infantis Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 121. North America Bifidobacterium Infantis Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. North America Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. North America Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 124. North America Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 125. North America Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 126. North America Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 127. North America Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 128. North America Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 129. North America Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 130. North America Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 131. North America Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 132. North America Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. North America Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. North America Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 135. Latin America Bifidobacterium Infantis Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Latin America Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. Latin America Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 138. Latin America Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 139. Latin America Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 140. Latin America Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 141. Latin America Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 142. Latin America Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 143. Latin America Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 144. Latin America Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 145. Latin America Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 146. Latin America Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Latin America Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. Latin America Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 149. Europe Bifidobacterium Infantis Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Europe Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Europe Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 152. Europe Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 153. Europe Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 154. Europe Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 155. Europe Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 156. Europe Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 157. Europe Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 158. Europe Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 159. Europe Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 160. Europe Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Europe Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Europe Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 163. Middle East Bifidobacterium Infantis Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Middle East Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. Middle East Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 166. Middle East Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 167. Middle East Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 168. Middle East Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 169. Middle East Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 170. Middle East Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 171. Middle East Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 172. Middle East Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 173. Middle East Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 174. Middle East Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Middle East Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. Middle East Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 177. Africa Bifidobacterium Infantis Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Africa Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Africa Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 180. Africa Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 181. Africa Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 182. Africa Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 183. Africa Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 184. Africa Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 185. Africa Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 186. Africa Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 187. Africa Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 188. Africa Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Africa Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. Africa Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 191. Global Bifidobacterium Infantis Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. ASEAN Bifidobacterium Infantis Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. ASEAN Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. ASEAN Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 195. ASEAN Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 196. ASEAN Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 197. ASEAN Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 198. ASEAN Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 199. ASEAN Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 200. ASEAN Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 201. ASEAN Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 202. ASEAN Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 203. ASEAN Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. ASEAN Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 205. ASEAN Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 206. GCC Bifidobacterium Infantis Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. GCC Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. GCC Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 209. GCC Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 210. GCC Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 211. GCC Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 212. GCC Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 213. GCC Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 214. GCC Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 215. GCC Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 216. GCC Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 217. GCC Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. GCC Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. GCC Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 220. European Union Bifidobacterium Infantis Market Size, by Group, 2017-2032 (USD Million)
TABLE 221. European Union Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. European Union Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 223. European Union Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 224. European Union Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 225. European Union Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 226. European Union Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 227. European Union Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 228. European Union Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 229. European Union Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 230. European Union Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 231. European Union Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. European Union Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 233. European Union Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 234. BRICS Bifidobacterium Infantis Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. BRICS Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. BRICS Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 237. BRICS Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 238. BRICS Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 239. BRICS Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 240. BRICS Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 241. BRICS Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 242. BRICS Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 243. BRICS Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 244. BRICS Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 245. BRICS Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. BRICS Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 247. BRICS Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 248. G7 Bifidobacterium Infantis Market Size, by Group, 2017-2032 (USD Million)
TABLE 249. G7 Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. G7 Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 251. G7 Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 252. G7 Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 253. G7 Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 254. G7 Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 255. G7 Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 256. G7 Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 257. G7 Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 258. G7 Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 259. G7 Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. G7 Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. G7 Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 262. NATO Bifidobacterium Infantis Market Size, by Group, 2017-2032 (USD Million)
TABLE 263. NATO Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. NATO Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 265. NATO Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 266. NATO Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 267. NATO Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 268. NATO Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 269. NATO Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 270. NATO Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 271. NATO Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 272. NATO Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 273. NATO Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. NATO Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. NATO Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 276. Global Bifidobacterium Infantis Market Size, by Country, 2017-2032 (USD Million)
TABLE 277. United States Bifidobacterium Infantis Market Size, 2017-2032 (USD Million)
TABLE 278. United States Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. United States Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 280. United States Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 281. United States Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 282. United States Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 283. United States Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 284. United States Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 285. United States Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 286. United States Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 287. United States Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 288. United States Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. United States Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 290. United States Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 291. Canada Bifidobacterium Infantis Market Size, 2017-2032 (USD Million)
TABLE 292. Canada Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. Canada Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 294. Canada Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 295. Canada Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 296. Canada Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 297. Canada Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 298. Canada Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 299. Canada Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 300. Canada Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 301. Canada Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 302. Canada Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. Canada Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 304. Canada Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 305. Mexico Bifidobacterium Infantis Market Size, 2017-2032 (USD Million)
TABLE 306. Mexico Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. Mexico Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 308. Mexico Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 309. Mexico Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 310. Mexico Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 311. Mexico Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 312. Mexico Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 313. Mexico Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 314. Mexico Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 315. Mexico Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 316. Mexico Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. Mexico Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 318. Mexico Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 319. Brazil Bifidobacterium Infantis Market Size, 2017-2032 (USD Million)
TABLE 320. Brazil Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. Brazil Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 322. Brazil Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 323. Brazil Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 324. Brazil Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 325. Brazil Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 326. Brazil Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 327. Brazil Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 328. Brazil Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 329. Brazil Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 330. Brazil Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. Brazil Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 332. Brazil Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 333. United Kingdom Bifidobacterium Infantis Market Size, 2017-2032 (USD Million)
TABLE 334. United Kingdom Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 335. United Kingdom Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 336. United Kingdom Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 337. United Kingdom Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 338. United Kingdom Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 339. United Kingdom Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 340. United Kingdom Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 341. United Kingdom Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 342. United Kingdom Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 343. United Kingdom Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 344. United Kingdom Bifidobacterium Infantis Market Size, by End User, 2017-2032 (USD Million)
TABLE 345. United Kingdom Bifidobacterium Infantis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 346. United Kingdom Bifidobacterium Infantis Market Size, by Online, 2017-2032 (USD Million)
TABLE 347. Germany Bifidobacterium Infantis Market Size, 2017-2032 (USD Million)
TABLE 348. Germany Bifidobacterium Infantis Market Size, by Application, 2017-2032 (USD Million)
TABLE 349. Germany Bifidobacterium Infantis Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 350. Germany Bifidobacterium Infantis Market Size, by Clinical Therapeutics, 2017-2032 (USD Million)
TABLE 351. Germany Bifidobacterium Infantis Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 352. Germany Bifidobacterium Infantis Market Size, by Infant Nutrition, 2017-2032 (USD Million)
TABLE 353. Germany Bifidobacterium Infantis Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 354. Germany Bifidobacterium Infantis Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 355. Germany Bifidobacterium Infantis Market Size, by Liquid, 2017-2032 (USD Million)
TABLE 356. Germany Bifidobacterium Infantis Market Size, by Powder, 2017-2032 (USD Million)
TABLE 357. Germany Bifidobacterium Infantis Market Size, by Sachet, 2017-2032 (USD Million)
TABLE 358. Germany Bifidobacterium I

Companies Mentioned

  • Alimentary Health Limited
  • Alpspure Lifesciences Private Limited
  • Archer Daniels Midland Company
  • Bifido Co., Ltd.
  • Bio Fermen Private Limited
  • Biocodex, Inc.
  • BioGaia AB
  • Brukem Life Care Pvt. Ltd.
  • Chr. Hansen Holding A/S
  • Culture Systems Inc
  • Danone S.A.
  • DuPont de Nemours, Inc.
  • Evolve Biosystems
  • Fengchen Group Co., Ltd.
  • GLAC Biotech
  • Kerry Group PLC
  • Lallemand Inc.
  • Morinaga Milk Industry Co., Ltd.
  • Nestlé S.A.
  • Ninsar Nutrascience Private Limited
  • Probi AB
  • Probiotical SpA
  • Sabinsa Corporation
  • Sacco System
  • Sapra Healthcare
  • SK BIOBIZ AGRO PRIVATE LIMITED
  • Synbio Tech Inc.
  • Unique Biotech Limited

Related Topics

Related Reports

Bifidobacterium Longum Subsp. Infantis M-63 Market - Global Forecast 2026-2032 - Product Image

Bifidobacterium Longum Subsp. Infantis M-63 Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Bifidobacterium - Global Strategic Business Report - Product Image

Bifidobacterium - Global Strategic Business Report

  • Report
  • 293 Pages
  • Global
From
Bifidobacterium Longum Lysate (CAS 96507-89-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Bifidobacterium Longum Lysate (CAS 96507-89-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Psychobiotic Supplements Market - Global Forecast 2025-2032 - Product Image

Psychobiotic Supplements Market - Global Forecast 2025-2032

  • Report
  • 188 Pages
  • Global
From
Probiotic Dietary Supplement - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Probiotic Dietary Supplement - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.